Hereditary angioedema with C1-inhibitor deficiency (HAE-C1-INH) is a rare disease resulting in unpredictable attacks of swelling under the skin. touchIMMUNOLOGY were delighted to speak with Dr. Andreas Recke (University of Lübeck, Lübeck, Germany) around the health burden of HAE-C1-INH and the unmet needs in its treatment.
The abstract ‘Lanadelumab Treatment Patterns Among Patients With HAE-C1-INH: Interim Analysis of the ENABLE Study.’ was presented at EAACI 2022, 1-3 July, 2022.
Questions
- Could you tell us a little about the health burden of hereditary angioedema with C1 inhibitor deficiency (HAE-C1-INH)? (0:25)
- What are the unmet needs in the treatment of HAE-C1-INH? (2:18)
Disclosures: Andreas Recke has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
Filmed in coverage of the EAACI Hybrid Congress 2022.
